The peptide protocol companion.
Reconstitution math, pharmacokinetic decay curves, injection logging, and a library of 100+ compounds. Built for the people who take their protocols seriously.
No spam. One email when we launch.
- Jastreboff et al. · NEJM 2023
- Ocampo et al. · Longevity 2023
- Epic EMR cohort · n = 170,000
A complete protocol tool. Not another tracker.
Three views, all working together. Real data. Real citations. No guesswork on dose math or when your next injection lands.
Dashboard
Live protocol status, next injection, and pharmacokinetic decay curves tied to your real half-lives.
Reconstitution
Vial + bac water + target dose → exact draw in insulin units. Every new user's first question, solved.
Peptides
105 compounds with half-lives, dose ranges, storage, and reconstitution defaults. Searchable, filterable.
You're running 3 peptides. Your tracker handles one.
Every GLP-1 tracker on the App Store is built for semaglutide users. If your stack includes BPC-157, TB-500, ipamorelin, or anything beyond the one-shot-per-week GLP-1 pattern, they fall apart.
PinPal was built from the first protocol logged. Multi-peptide is the default, not an afterthought.
- SemaglutideGLP-1t½ 7d
- BPC-157Healingt½ 4h
- IpamorelinGrowtht½ 2h
- TB-500Healingt½ 2d
- SermorelinGrowtht½ 12m
- GHK-CuCosmetict½ 3h
Six compounds · four categories · half-lives spanning 12 minutes to 7 days. A single-peptide tracker can't reason about this.
Built for the daily driver.
Every dose, every window, logged.
Tap-to-log injections tied to peptide, dose, site, and time. Miss a dose and PinPal rebalances the schedule — no guesswork on the next window.
The math you were going to do on a napkin.
Pick your peptide, enter vial and bac water, set the target dose. PinPal returns the exact draw in U-100 insulin units.
Decay curves plotted against your real half-lives.
First-order exponential decay for every compound in your stack, modeled against published clinical half-lives. See when the last dose clears and when the next lands.
Side effects, correlated — not just logged.
Daily check-ins map symptoms against dose, site, and time. PinPal surfaces the patterns you'd miss in a notes app.
Rotate sites the way clinicians recommend.
A 2D body map remembers your last eight injection sites per peptide. Keep the rotation clean without burning out the same spot.
Export a clean report for your provider.
One-tap PDF with your protocol, dose log, symptoms, and weight trend. Built for longevity clinics and telehealth providers.
Every decision cited. Every number checked.
Peptides in the library at launch, with half-lives, dose ranges, and reconstitution defaults.
Americans currently on semaglutide, tirzepatide, or retatrutide protocols.
Off GLP-1 medication at 36 months per Epic EMR cohort. Adherence crisis, not a pharmacology one.
Of longevity peptide combinations that shortened lifespan in Ocampo et al. Stacking needs awareness.
Sources: Jastreboff et al., NEJM 2023 · Ocampo et al., Longevity 2023 · Epic EMR cohort n=170,000, 2024 · Published clinical half-lives for each compound in the library. For informational purposes only. Not medical advice. Always consult your healthcare provider.
The ones we get most often.
No. PinPal is a tracking and information tool. It does not diagnose, treat, or prescribe. Every dose, interaction, and side-effect note is for informational purposes only. Always consult your healthcare provider before starting or changing any peptide protocol.
At launch: 105 compounds across GLP-1s (semaglutide, tirzepatide, retatrutide), healing peptides (BPC-157, TB-500), growth hormone secretagogues (sermorelin, CJC-1295, ipamorelin), and cosmetic peptides (GHK-Cu, epithalon). We add compounds continuously based on community requests.
Yes. If you're on semaglutide or tirzepatide alone, PinPal works as a focused single-peptide tracker with the best reconstitution calculator on the market. The multi-peptide architecture is there when and if you need it.
Your protocol log lives in an encrypted database tied only to your account. We do not sell, share, or mine your data. We do not serve ads. Apple and Google sign-in are supported for passwordless auth.
Submitted to the App Store. We'll email everyone on the waitlist the moment review clears.
iOS first. Android is on the roadmap after we've validated the experience on iOS and shipped the first set of wearable integrations.
A free tier covers one or two protocols plus the reconstitution calculator. A paid tier unlocks unlimited stacks, symptom intelligence, decay curves, and the provider share report. Final pricing will be announced at launch.
Get in early. Stay serious.
One email the moment PinPal is available in the App Store. No newsletter. No marketing noise. Unsubscribe in a click.